3 names to watch on biotech beatdown

The cholesterol drug space is set to get more crowded, and "Fast Money" traders believe one biotech company should benefit most.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.